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Background: Bovine viral diarrhoea (BVD) is considered eradicated from Denmark. Currently, very few (if any) Danish
cattle herds could be infected with BVD virus (BVDV). The Danish antibody blocking enzyme-linked immunosorbent
assay (ELISA) has been successfully used during the Danish BVD eradication program, initiated in 1994. During the last
decade, the cattle herd size has increased while the prevalence of BVDV has decreased. In this study, we investigated
how these changes could affect the performance of the Danish blocking ELISA and of the SVANOVIR®BVDV-Ab indirect
ELISA. The latter has successfully been used to eradicate BVD in Sweden.
Data (2003–2010) on changes in median herd size and milk production levels, occurrence of viremic animals and bulk
milk surveillance were analysed. Additionally, the Danish blocking ELISA and the SVANOVIR ELISA were compared
analyzing milk and serum samples. The prevalence of antibody positive milking cows that could be detected by each
test was estimated, by diluting positive individual milk samples and making artificial milk pools.
Results: During the study period, the median herd size increased from 74 (2003) to 127 cows (2010), while the
prevalence of BVDV infected herds decreased from 0.51 to 0.02 %. The daily milk yield contribution of a single
seropositive cow to the entire daily bulk milk was reduced from 1.61 % in 2003 to 0.95 % in 2010 due to the
increased herd size. It was observed that antibody levels in bulk milk decreased at national level. Moreover, we
found that when testing bulk milk, the SVANOVIR®BVDV-Ab can detect a lower prevalence of seropositive lactating
cows, compared to the Danish blocking ELISA (0.78 % vs. 50 %). Values in the SVANOVIR®BVDV-Ab better relate to
low concentrations of antibody positive milk (R2 = 94-98 %), than values in the blocking ELISA (R2 = 23–75 %). For
sera, the two ELISAs performed equally well.
Conclusions: The SVANOVIR ELISA is recommended for analysis of bulk milk samples in the current Danish situation,
since infected dairy herds e.g. due to import of infected cattle can be detected shortly after BVDV introduction, when
only few lactating cows have seroconverted. In sera, the two ELISAs can be used interchangeably.
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Antibody enzyme-linked immunosorbent assays (ELISAs)
are commonly used for bulk milk surveillance for bovine
viral diarrhoea (BVD). The level of antibodies against BVD
virus (BVDV) in bulk milk relates to the prevalence of
BVDV seropositive lactating cows in the dairy herd [1]. In
Denmark, if the bulk milk is classified as positive, blood is
sampled from 25–30 individual animals to find at least one
serum-antibody positive animal (with 95 % confidence, as-
suming a 10 % within-herd prevalence) and to confirm the
herd infection status. If no antibody positive animals are
detected, the herd is classified as BVD negative, but high
bulk milk titers are taken into consideration. If the herd is
confirmed positive (i.e. infected) by analysing serum, all an-
imals are sampled and their blood tested for presence of
BVDV antibodies. Seronegative cattle are tested for virus
to find and cull persistently infected (PI) cattle. Moreover,
animal movements are put under restriction until all PI an-
imals have been eliminated from the herd (usually during a
one-year-period from first BVDV detection). The Danish
blocking ELISA [2, 3] has successfully been used in the na-
tional BVD eradication programme [4], which was initiated
in 1994 [5, 6]. This study presents data from 2003 to 2010,
when Danish dairy herds were screened quarterly by bulk
milk testing. During this period the average herd size had
increased, which was reflected in an increase in the vol-
umes of milk produced by individual herds. These changes
could have resulted in a greater dilution of individual
BVDV antibodies in bulk milk.
In Denmark, in 2010, the birth of PI animals was ex-
tremely rare, and could be caused by indirect contact to
foreign cattle herds or import of pregnant cattle. This is in
contrast to the situation in 1994, when herds had seroposi-
tive cows. During the eradication programme, the antibody
titer in bulk milk in all herds was expected to decrease. An
evaluation of the BVD surveillance system is therefore re-
quired to ensure that BVDV antibody positive herds are
readily detected. The ELISA must be able to detect a low
prevalence of antibody positive cows, like a single cow in
the population contributing to the bulk milk sample. Early
detection of newly infected herds is crucial to control BVD.
The aims of this study were: (i) to investigate how
changes in the size of Danish dairy herds and BVD
prevalence from 2003 to 2010 might have affected the
surveillance based on two antibody ELISAs and (ii) to
compare the Danish blocking ELISA [2, 3] and the SVA-
NOVIR®BVDV-Ab ELISA (Svanova Boehringer Ingel-
heim, Uppsala, Sweden) [1, 7–9] for detection of BVDV
antibodies in milk and sera.
Methods
Population data and BVD status (2003–2010)
Data collected between 2003 and 2010 were obtained
from the Danish Cattle Federation. The dataset containedthe central husbandry registration (CHR) number of the
herds, records of milk production (kg/herd/week), the
herd size (number of cows/herd/month) and a quantita-
tive account of the antibody level detected by the
Danish blocking ELISA (in blocking percentage) in bulk
milk samples. The value of Danish blocking ELISA will
from here be referred as bl%. Data on animals being
BVDV positive (e.g. date of birth and date of testing)
were also included.
To investigate how the herd size and levels in milk
production changed during the period, the annual num-
ber of dairy herds (from January to December), the herd
size, the overall national milk production level and the
daily amount of milk (kg) delivered per herd and per
cow, were calculated for all years (2003–2010).
The daily milk contribution (in %) of a seropositive
lactating cow to the bulk milk, was estimated assuming
that (i) all lactating cows had similar milk production
and (ii) approximately 17 % (minimum 12 % and max-
imum 20 %) of the cows present in the herd were dry
and did not contribute to the bulk milk. For example, in
a herd with 74 cows, we assumed that the average daily
number of lactating cows was 62 (minimum 59, max-
imum 65). Hence, the average individual milk contribu-
tion to the bulk milk was 1/62 = 1.61 % (1.54 %; 1.70 %)
(Table 1). The proportion of dry cows was based on our
knowledge of the Danish dairy industry.
To study changes in the infection status, the preva-
lence of herds with viremic animals was estimated by
calculating the annual proportion of herds with at least
one BVDV positive animal. Herds that ceased with pro-
duction during the year were also considered.
The Danish bulk milk values (in bl%) were investi-
gated for each year, using data on antibody detection in
bulk milk.
The freeware R (version 2.13.2, R core development
team, 2010) and Excel (Microsoft Office, 2007) were
used for data analysis.
Antibody ELISAs
The Danish blocking ELISA was performed as previously
described [2]. For this test, the sensitivity (Se) and speci-
ficity (Sp) when applied to individual milk samples have
not been estimated. In bulk milk, when the prevalence
of infected herds was 26 %, estimates of Se and Sp
were 100 % and 62 % respectively, using a cut-off bl%
of 50 [10].
Currently, the decision criteria used by the Danish
Cattle Federation to consider a herd as positive, based
on bulk milk testing, is an increase in the blocking per-
centage to 50 % [3, 5, 10] and/or two consecutive bulk
milk samples ≥ 20 %. In this study, individual milk, bulk
milk samples and milk pools were defined as positive if
the bl% was above 0, according to the current antibody
Table 1 Changes in number of milking cows per Danish herd and their individual contribution to the bulk milk
Parameter 2003 2010
80 % 83 % 88 % 80 % 83 % 88 %
a 59 (463) 62 (480) 65 (509) 101 (948) 105 (984) 111 (1043)
b 25 (28) 25 (27) 23 (26) 29 (32) 28 (31) 26 (29)
c 1.70 (0.22) 1.61 (0.21) 1.54 (0.20) 0.99 (0.11) 0.95 (0.10) 0.90 (0.10)
Parameters a, b and c were estimated based on data from the Danish diary industry, assuming that usually 17 % of the cows in a herd are dry and not
contributing to the bulk milk. Therefore, usually 83 % of the cows are lactating, 80 % is the minimum and 88 % is the maximum proportion of lactating cows. a)
Number of lactating cows/herd/day according to median herd size in 2003 (74 cows) and 2010 (127 cows), b) amount of milk produced (kg) per cow/day and c)
daily contribution of a single cow to the bulk milk (in %). The estimates for the largest herds in 2003 (579 cows) and 2010 (1185 cows) are shown in brackets
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the bl% was close to 0 in 2010 (see results). This could be
due to eradication of BVD from Denmark, and/or because
the dilution of individual BVDV antibodies in bulk milk is
too high to allow detection by the used ELISA.
In individual serum, the Se and Sp are 96.5 % and
97.5 % respectively, if a cut-off bl% of 50 is used [2].
The ELISA SVANOVIR®BVDV-Ab [1, 7–9] was per-
formed according to the instructions from the manufac-
turer. Values were calculated as percentage positivity
(PP), and individual milk samples were considered posi-
tive if PP ≥ 9. In this study, diluted milk samples and
artificial pools of milk representing bulk milk were clas-
sified as positive if PP was ≥ 2. According to the manu-
facturer, this value corresponds to a low antibody level
in the herd. In serum, the reported Se and Sp are 100 %
and 98.2 % respectively [11], using PP of 15 as indicative
of an antibody positive sample.
Milk and serum testing
Individual milk and serum samples were obtained from
three Danish dairy herds (A, B and C), which contained
BVD antibody positive and antibody negative lactating
cows. Herd A was determined to be a BVDV positive
herd (5th October 2011) due to an increase in the bulk
milk antibody titre after birth of PI calves. Herd B was
suspected of BVDV infection following an increase in
BVDV antibody titre in bulk milk in November 2010. A
serological analysis of the herd revealed that imported
pregnant heifers had given birth to PI animals in January
2010. The route of BVDV introduction in herd C is un-
known. During the study period (2010–2011), the herd
size in herds A, B and C was around 350, 180, and 259
cows, respectively.
To evaluate the impact of larger herds and of a reduced
in-herd prevalence of BVDV antibody positive cows on
the surveillance system for Danish dairy herds, the Danish
blocking ELISA and the SVANOVIR were compared. The
minimum prevalence of BVDV antibody positive cows
needed to be able to detect a positive antibody titre in a
bulk milk sample was compared. Experiments were car-
ried out by a) analysing dilutions of antibody positive indi-
vidual milk samples and b) analysing artificially made bulkmilk samples with a known proportion of antibody posi-
tive milk.
Dilution experiments were performed on individual
samples from herd A, where serum and milk were col-
lected from 303 lactating cows. Of these, 149 cows were
selected randomly for our study. Thereafter, milk sam-
ples from 77 cows that were positive in both ELISAs in
milk and serum were divided into three groups accord-
ing to their antibody titer in the Danish blocking ELISA:
low (L, n = 19 cows), medium (M, n = 38) and highly (H,
n = 20) positive, according to the 1st and 3rd quartiles of
the bl% in milk (12 % and 34 %, respectively). The mini-
mum and maximum bl% were 0.3 % and 96 %. There-
after, three cows in group L, three cows in group M and
four cows in group H were randomly selected. Milk and
serum samples from these ten lactating cows were seri-
ally two-fold diluted in seven dilution steps from 1/2 up
to 1/128 in BVDV antibody negative milk or serum, re-
spectively. BVDV antibody negative milk and serum
samples used for the dilutions were tested negative in
both ELISAs.
Artificial bulk milk samples were made from ten posi-
tive and 31 negative cows from herds B and C. In this
experiment, cows were classified as positive or negative
according to bl% in milk. Antibody positive and negative
milk pools were made; cows contributing to the positive
milk pool had milk bl% between 89 % and 97 %, and
serum bl% between 98 % and 99 %. Nineteen artificial
bulk milk samples of 5 ml. each were constructed, they
contained 10–100 % BVDV antibody positive milk, di-
luted in antibody negative milk. To focus on bulk milk
series with low antibody levels, we additionally analysed
12 artificial bulk milk samples with concentrations of
positive milk from 2.5 to 30 %, with increments of 2.5
percentage points.
Original bulk milk samples, collected from herds B
and C, were analysed using both ELISAs to compare the
antibody levels after removal of PI animals.
Linear regression model for artificial pools of milk
For the artificial pools of milk, a simple linear regression
model was used to examine the association between the
concentration of positive milk in an artificial bulk milk
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bodies measured by each ELISA (as an explanatory vari-
able). A log transformation was used for both variables.
The coefficient of determination (R2) was calculated to
estimate the variation in the proportion of positive milk
in a pooled sample, which can be explained by the values
obtained with the ELISA used.
Results
Descriptive statistics on herd size and BVD status in
Denmark
Between 2003 and 2010, the number of dairy herds de-
livering milk during a full year period decreased from
7075 to 4037. The median herd size was 74 cows in
2003 and 127 cows in 2010 (Fig. 1). The two largest
herds had 579 and 1185 cows, respectively. The overall
national milk production remained at the same level,
with approximately 4.4 billion kg in 2003 and 4.7 billion
kg in 2010 (Fig. 1).
The milk yield per cow increased by 3–4 kg during the
period, but due to the increased herd size, the contribu-
tion of a single animal to the daily herd’s production de-
creased from 1.61 to 0.95 % when comparing herds of
median size, and from 0.21 to 0.10 % when comparing
the largest herds present in 2003 and 2010 (Table 1).
In 2003, the prevalence of herds with at least one
BVDV positive animal was 0.51 % (39/7731), whereas in
2010 only 0.02 % (1/4255) were found to be virus posi-
tive. This was due to import of pregnant cows carrying
PI calves (herd B), which were not tested for BVD virus
when born.
In 2003, a total of 31,345 bulk milk samples were ana-
lysed. Of those, 95 % had a bl% below the cut-off 50 %. In
2010, 17,298 bulk milk samples were tested, 75 % of which
had a bl% of 0 (below detection level), while the remaining
25 % had a median bl% of 5 (3rd quartile = 9 %). The max-
imum value obtained was bl% = 80 in herd B.Fig. 1 Changes in the size and milk production of Danish dairy herds from
Herd =milk produced per herd (in 100,000 kg). Herds/Year = number of Da
December; Milk/Year = national milk production (in billion kg of milk)Seroprevalence in herd A
In herd A, the prevalence of individual antibody positive
milk and serum samples detected by the blocking ELISA
was 56 % and 71 %, respectively. Five cows tested posi-
tive in milk but not in serum. The SVANOVIR tested
87 % and 69 % positive, respectively, since 27 cows
tested positive in milk but not in serum. These 27 cows
were not considered for the dilution experiments, as
they were not confirmed as true positives. Only samples
from animals positive in both tests, in both milk and
sera were used.
Dilution series in milk and serum
In the milk dilution experiments, the SVANOVIR was
positive in all ten milk samples in all dilution steps to 1/
128 (Fig. 2). When using the blocking ELISA two cows
from the highly positive group were positive in milk in
the blocking ELISA at dilution 1/2, while all ten animals
were negative at dilutions ≥ 1/4. Moreover, animals in
the low positive group (L) showed bl% = 0 even in the
undiluted sample (Fig. 2).
In the serum dilution experiment the two ELISAs had
comparable results (Fig. 3). One cow from group M was
negative in the blocking ELISA at dilution 1/64 (bl% =
45), the same cow was antibody negative at the same di-
lution in the SVANOVIR (PP = 14), together with an-
other cow from the same group (PP = 13).
Artificial bulk milk series
In artificial bulk milk series with 10–100 % BVDV anti-
body positive milk, the relation between test values and
the concentration of positive milk was significant for
both tests (P-value < 0.0001). The R2 was 75 % for the
blocking ELISA and 98 % for the SVANOVIR. However
when analysing pools with low antibody titters, 2.5–30 %
positive milk, no significant relation between the bl%
and the concentration of positive milk (P-value = 0.12)2003 to 2010. Cows/Herd =median herd size (divided by 10); Milk/
nish dairy herds (in 1,000), which delivered milk from January to
Fig. 2 Results obtained on diluted individual milk samples. On the x-axis, 1 corresponds to the undiluted sample, while 2-8 represent dilution
steps 1/2 up to 1/128. □ =mean bl% using the Danish blocking ELISA; Δ =mean PP-value using the SVANOVIR. Grey bars represent 95 % confidence
interval around each mean, H: highly positive group (n = 4), M: medium positive group (n = 3), and L: low positive group (n = 3). Horizontal dashed
lines represent the cut-offs (bl% = 0 and PP = 2), above which samples were classified as antibody positive. N.B. Test values below zero do not have
any biological meaning, and thus, in the 95 % confidence intervals we set the minimum bar limit to 0. We proceeded in a similar way for the
maximum limit of the blocking ELISA, which cannot have values > 100 %
Fig. 3 Results obtained on diluted individual serum samples. On the x-axis, 1 corresponds to the undiluted sample, while 2-8 represent dilution
steps 1/2 up to 1/128. □ =mean bl% with the Danish blocking ELISA; Δ =mean PP-value using the SVANOVIR. Grey bars represent 95 % confidence
interval around each mean, H: highly positive group (n = 4), M: medium positive group (n = 3), and L: low positive group (n = 3). Horizontal dashed
lines represent the cut-offs (bl% = 50 and PP = 15) above which samples were classified as antibody positive. N.B. Test values below zero do not have
any biological meaning, and thus, in the 95 % confidence intervals we set the minimum bar limit to 0. We proceeded in a similar way for the
maximum limit of the blocking ELISA, which cannot have values > 100 %
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and 94 % for the SVANOVIR.
Bulk milk from herds B and C
Bulk milk samples from the field were analysed and both
ELISAs classified herd B as positive (bl% = 44; PP = 58)
149 days after removal of the last born PI calf. Herd C
was classified negative in the blocking ELISA after
503 days (bl% = 0), but still remained positive in the
SVANOVIR after 915 days (PP = 13) (Fig. 4).
Discussion
The Danish eradication programme was initiated in
1994 when 39 % of the herds were expected to contain
PI animals and the average herd size was 42 cows [5].
Since then the herd structure has changed and the BVD
incidence has decreased. The results from the present
study should provide important information on how to
proceed in the Danish BVD surveillance system.
Although important changes occurred in the number
and size of milking herds, the Danish milk production
remained at the same level between 2003 and 2010
(Fig. 1). A slight increase in milk production per cow
was observed, but the dilution of individual antibodies
increased steadily (Table 1) due to increased herd size.
The increase in the median Danish herd size was quite
sudden (Fig. 1) and the contribution of a single antibody
positive animal in a herd has become more difficult to
detect in bulk milk testing (Table 1).
Our epidemiological investigations showed that BVD
is at present an exotic disease in Denmark, because the
prevalence of herds with viremic cattle decreased stead-
ily during the investigated years, now only sporadic cases
are detected.
The antibody titer in Danish bulk milk samples de-
creased and most of the samples were below the detec-
tion level of antibodies in 2010. Accordingly, we usedFig. 4 Change in bulk milk values after removal of all PI calves (herds B an
herd B and 915 days for herd C. The y-axis represents the bl% and PP-value
while the x-axis represents the number of days since removal of the last bo
tested from herds B and C respectivelycut-off bl% = 0 to classify a milk sample as positive with
the blocking ELISA. Using this criterion, most Danish
dairy herds were considered to be naïve to BVDV.
Therefore, we did not have access to bulk milk samples
and individual milk/serum samples from more than the
three previously infected herds (A, B, and C), for our ex-
periments. We used the dilution experiments and artifi-
cial pools of milk, to investigate the impact of a changed
herd structure and antibody dilution level, comparing
the original Danish blocking ELISA and the new SVA-
NOVIR ELISA. Moreover, to represent the bulk milk in
our experiments, we assumed that all milking animals
produced a similar amount of milk and that all seroposi-
tive animals had the same antibody titre. In reality this is
not the case, and thus, we used a simplification. For in-
stance, the concentration of antibodies in individual milk
could be higher at the beginning and at the end of lacta-
tion [8] or if a cow carries a PI calf [12]. Nevertheless, we
think that our experiments give important information on
the comparison of the two tests when used for bulk milk
testing. As shown by Graat et al. [13], for infectious bo-
vine rhinotracheitis (IBR), the threshold prevalence of
antibody positive cows at which the ELISA used can clas-
sify the bulk milk as positive, is a parameter that needs se-
vere consideration, since it affects the detection time and
the performance of the surveillance system.
We found that the SVANOVIR ELISA can classify the
bulk milk as positive, at a lower prevalence of seroposi-
tive cows (and thus sooner after BVDV introduction)
than the blocking ELISA. Therefore, the SVANOVIR
ELISA could be used to optimize the Danish surveillance
system in dairy herds.
In the dilution experiments, it was found that the
SVANOVIR could detect one single antibody positive
animal, corresponding to an individual contribution of
0.78 % (1/128) to the bulk milk (Fig. 2) in more than half
of the herds (with ≤ 128 milking cows). We consideredd C). Results from two dairy herds during a 149 days evaluation for
s according to the blocking ELISA and the SVANOVIR respectively,
rn PI calf and the bulk milk sampling. Four and fifteen samples were
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lactating cows would have approximately 145 cows (con-
sidering that at least 12 % are dry), which is close to the
most common herd size in Denmark.
On average, one cow can contribute to 0.90–0.99 % of
the overall herd’s production (Table 1), and therefore re-
cently infected herds could be detected soon after infec-
tion when the number of antibody positive animals is
low. In the largest herds, with 129–1043 lactating cows
and a herd size of 147 and 1185 cows respectively, two
to nine animals should be antibody positive to result in a
positive BVD bulk milk antibody value. With the block-
ing ELISA, at least 50 % of the milking cows should be
positive (Fig. 2) to be detectable in a bulk milk sample.
This finding is in agreement with the prevalence of anti-
body positive milking cows in herd A at the time of
BVD detection by bulk milk testing.
Regarding the animals in the “L” group, which showed
milk bl% = 0 in all dilution steps (Fig. 2) it must be men-
tioned that, any ELISA when repeated, is very unlikely to
give exactly the same values. In the first test (when we
tested all cows for the first time), the three animals of the
“L” group had bl% > 0 in milk. Those animals were also
positive in milk in the SVANOVIR and in serum with
both ELISAs and were assumed to be true positives.
Nevertheless, when we repeated the test for the dilution
trials, these cows were negative in the undiluted milk sam-
ple with the blocking ELISA (Fig. 2). This means that es-
pecially in low positive animals, the repeatability and
robustness on milk samples is low for the blocking ELISA.
Furthermore, the linear regression model with the
SVANOVIR’s values as x-variable explained 94–98 % of
the variation in the concentration of positive milk pool
used (y-variable), while the model with the blocking
ELISA could explain 23–75 %. At low concentrations of
positive milk (2.5–30 %) the explanatory power of both
tests was lower and was not significant for the blocking
ELISA. Thus, especially when analysing bulk milk from
herds with few positive cows, the SVANOVIR relates
better to the low prevalence of positive lactating cows
contributing to the bulk milk.
A low Se in milk is a common problem for blocking
ELISAs and a high prevalence of seropositive lactating
cows could be needed before bulk milk samples are anti-
body positive [14]. Therefore, the threshold prevalence
(50 %) estimated in the dilution experiments to have
positive bulk milk appears correct. In this kind of ELISA
system, the cause of low Se in milk and high Se in paired
serum could be explained by a well-buffered environ-
ment in serum, whereas milk samples may have a low
pH due to acidic bacteria that make the milk sour. This
creates a suboptimal environment for the antigen-
antibody binding. Moreover, antibody levels are lower in
milk than in serum [15].With the SVANOVIR, in herd A, 27 cows were posi-
tive in milk but negative in serum. This was a surprising
finding, because it was expected that milk would have a
lower titre than serum [15]. According to the veterinar-
ians who carried out the sampling, mismatching of milk
and serum samples was unlikely, especially since a very
high percentage of animals (27/149 = 18 %) showed this
unexpected result. With the Danish blocking ELISA, this
percentage was by far lower (5/149 = 3.4 %). Similar re-
sults to ours were found in the study by Niskanen et al.
[8]. Thus, higher positivity in milk compared to serum
can sometimes be found, when the SVANOVIR is used.
With this test, serum is tested after dilution, while milk
is tested undiluted. Schrijver and Kramps [16] suggested
that when indirect ELISAs are used, as is the case with
the SVANOVIR, samples should be diluted before ana-
lysis to avoid unspecific binding of antibodies. Unspecific
binding is a common problem for indirect ELISAs, e.g.
because non-specific antibodies bind to the well and, de-
pending on the washing conditions, they will be detected
by the conjugated antibody.
If the SVANOVIR is selected for bulk milk testing, a
preliminary screening of all dairy herds present in the
country could be made, to define the baseline national
antibody status (according to the new test). In herds
with positive or doubtful bulk milk reactions a pooled
milk sample from cows in their first lactation, which
should be naive to BVDV, could be tested. Using this
system, new infections are detected and the proportion
of false positive bulk milk samples could be defined for
the SVANOVIR ELISA. This is necessary, since the in-
vestigation of a herd suspected of having BVDV based
on antibodies in bulk milk, will require additional testing
of individual animals at the cost of about 800–900 Euro.
Regarding results from bulk milk samples of herds B
and C (Fig. 4), we showed that the SVANOVIR required
more time to become negative again after removal of PI
animals. At this stage, alternative testing strategies are
used in the herd, like testing of serum from young ani-
mals born after culling of PIs from the herd [17]. More-
over, while in herd C both tests showed decreasing bulk
milk antibody titers; in herd B, the SVANOVIR showed
an increasing trend after removal of the last born PI,
while the Danish blocking ELISA had steadily decreasing
values (Fig. 4). These differences between tests could be
caused by more PI(s) cattle being born in the herd but
having died before being detected by the veterinarians,
who carried out the sampling according to the BVDV
programme. The introduction of such a PI calf could
have been signalled in the bulk milk by the SVANOVIR
and not by the blocking ELISA.
Finally, when analysing serum samples for antibodies
to BVDV, we found that both ELISA’s has similar sensi-
tivity (Fig. 3). Both ELISA’s can be used to analyse serum
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cows which could carry PI calves) or to conduct follow-
up studies in dairy herds suspected of being infected.
Conclusions
The combination of increased dilution of individual anti-
bodies in bulk milk and decreased BVDV antibody preva-
lence is a challenge for the surveillance programmes. In
countries with large dairy herds and with low BVDV
prevalence (e.g. Denmark), the SVANOVIR could be pre-
ferred for an early warning surveillance system based on
bulk milk testing, because a lower prevalence of seroposi-
tive milking cows can be detected (compared to the
situation where the Danish blocking ELISA is used). Ana-
lysis of individual blood could be performed using either
of the two ELISAs.
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